Blood Transfusion in Cytoreductive Surgery: Better Not at All Eran NizriShigeki KusamuraMarcello Deraco ASO Author Reflections 01 October 2018 Pages: 711 - 712
Air Bubble Sign: ANew Screening Method for Anastomotic Leakage After Esophagectomy for Esophageal Cancer Yoshiaki ShojiHiroya TakeuchiYuko Kitagawa ASO Author Reflections 01 October 2018 Pages: 713 - 714
ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma Hiroshi OkumuraMasahiro NodaShoji Natsugoe ASO Author Reflections 04 October 2018 Pages: 715 - 716
ASO Author Reflections: New TNM Classification of Gastric Cancer Jun LuZhi-Fang ZhengChang-Ming Huang ASO Author Reflections 16 October 2018 Pages: 717 - 718
ASO Author Reflections: A Novel Muscle Measure for Gastric Cancer Zhi-Fang ZhengJun LuChang-Ming Huang ASO Author Reflections 08 October 2018 Pages: 719 - 720
ASO Author Reflections: A Population-Based Study on Lymph Node Retrieval in Patients with Esophageal Cancer L. R. van der WerfB. P. L. Wijnhoven ASO Author Reflections Open access 08 October 2018 Pages: 721 - 722
ASO Author Reflections: Survival Trends in Gastric Adenocarcinoma Johannes AsplundJesper Lagergren ASO Author Reflections Open access 08 October 2018 Pages: 723 - 724
ASO Author Reflections: Clinical Value of PET-CT for Gastric Cancer Michihiro KudouToshiyuki Kosuga ASO Author Reflections 09 October 2018 Pages: 725 - 726
ASO Author Reflections: Multimodal Enhanced Recovery After Surgery (ERAS) Program in Totally Laparoscopic Distal Gastrectomy for Gastric Cancer: What Have We Learned? So Hyun KangYoung Suk ParkSang-Hoon Ahn ASO Author Reflections 09 October 2018 Pages: 727 - 728
ASO Author Reflections: Malnutrition After Gastrectomy and Its Impact on Survival Keiichi FujiyaMasanori Terashima ASO Author Reflections 10 October 2018 Pages: 729 - 730
ASO Author Reflections: Immunoinflammatory Prognostics in Cancer Yusuke IshibashiHironori Tsujimoto ASO Author Reflections 08 October 2018 Pages: 731 - 732
ASO Author Reflections: Simplified Nomogram Predictive of Survival after R0 Resection for Gastric Cancer Zhi-Fang ZhengJun LuChang-Ming Huang ASO Author Reflections 10 October 2018 Pages: 733 - 734
ASO Author Reflections: Tumor Markers in Gastric Cancer Jun-Peng LinJian-Xian LinPing Li ASO Author Reflections 10 October 2018 Pages: 735 - 736
ASO Author Reflections: Current Treatment Options for Duodenal Adenocarcinoma—A Call for Collaborative Studies Laura L. MeijerGeert Kazemier ASO Author Reflections Open access 16 October 2018 Pages: 737 - 738
ASO Author Reflections: Quality of Life After HIPEC for Pseudomyxoma Peritonei Adam T. StearnsSarah T. O’Dwyer ASO Author Reflections 15 October 2018 Pages: 739 - 740
ASO Author Reflections: Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Yuji KumakuraTakehiko YokoboriHiroyuki Kuwano ASO Author Reflections 12 October 2018 Pages: 741 - 742
ASO Author Reflections: Endoscopic Management Will Be an Effective Treatment Option for Early Remnant Gastric Cancer, Similar to Primary Gastric Cancer Yudai FukuiHisashi Shinohara ASO Author Reflections 15 October 2018 Pages: 743 - 744
ASO Author Reflections: Post-Discharge Venous Thromboembolism Incidence and Risk Factors Pablo E. Serrano ASO Author Reflections 15 October 2018 Pages: 745 - 746
ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer John M. CreasyMichael I. D’Angelica ASO Author Reflections 17 October 2018 Pages: 747 - 748
ASO Author Reflections: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Gastric Cancer In-Hwan Kim ASO Author Reflections 15 October 2018 Pages: 749 - 750
ASO Author Reflections: Nodal Downstaging in Gastric Cancer Naruhiko IkomaBrian D. Badgwell ASO Author Reflections 23 October 2018 Pages: 751 - 752
ASO Author Reflections: Survival Impacts of Therapy and Complications in Gastric Adenocarcinoma Diego VicenteNaruhiko IkomaBrian D. Badgwell ASO Author Reflections 29 October 2018 Pages: 753 - 754
ASO Author Reflections: Predicting the Response of Esophageal Adenocarcinoma to Chemoradiotherapy Before Surgery Using MicroRNA Biomarkers Offers Hope to Improve Outcomes by Tailoring Treatment to Predicted Responses George C. MayneDavid I. WatsonDamian J. Hussey ASO Author Reflections 25 October 2018 Pages: 755 - 756
ASO Author Reflections: Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Z. J. LeeC. C. M. Teo ASO Author Reflections 29 October 2018 Pages: 757 - 758
ASO Author Reflections: Outcomes of Appendiceal Goblet Cell Carcinoid Tumors Erica S. TsangHagen F. Kennecke ASO Author Reflections 21 November 2018 Pages: 759 - 760
ASO Author Reflections: Multimodal Treatment of Upper Gastrointestinal Signet Ring Cell Containing Cancer—Better Together Ulrike HegerThomas Schmidt ASO Author Reflections 02 November 2018 Pages: 761 - 762
ASO Author Reflections: Recurrence Predictors in Mucinous Appendiceal Tumors Joel M. Baumgartner ASO Author Reflections 08 November 2018 Pages: 763 - 764
ASO Author Reflections: Prognostic Impact of Body Composition Change After Gastrectomy for Advanced Gastric Cancer Hyung Soon ParkJii Bum LeeMinkyu Jung ASO Author Reflections 12 November 2018 Pages: 765 - 766
ASO Author Reflections: Management of Malignant Peritoneal Mesothelioma Taylor R. CushmanVivek VermaCharles B. Simone II ASO Author Reflections 12 November 2018 Pages: 767 - 768
ASO Author Reflections: PCI is Not Predictive of Survival After Complete CRS/HIPEC for High-Grade Appendiceal Primaries Konstantinos ChouliarasKonstantinos I. Votanopoulos ASO Author Reflections 12 November 2018 Pages: 769 - 769
ASO Author Reflections: Long-Term Survival Is Feasible After Complete CRS/HIPEC for Biphasic Peritoneal Mesothelioma Konstantinos ChouliarasKonstantinos I. Votanopoulos ASO Author Reflections 12 November 2018 Pages: 770 - 771
ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis Joel M. BaumgartnerRazelle Kurzrock ASO Author Reflections 12 November 2018 Pages: 772 - 773
ASO Author Reflections: Low-grade Appendiceal Mucinous Neoplasia (LAMN): Which Criteria for a “Watch and Wait” Strategy? Marcello Guaglio ASO Author Reflections 27 November 2018 Pages: 774 - 775
ASO Author Reflections: Preoperative Venous Thromboembolism in Asymptomatic Patients Undergoing Major Oncologic Surgery Nicholas MangusoAllan W. Silberman ASO Author Reflections 19 November 2018 Pages: 776 - 777
ASO Author Reflections: Borrmann Type as a Characteristic Phenotype of Advanced Gastric Cancer Han Hong Lee ASO Author Reflections 12 November 2018 Pages: 778 - 779
ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Tomoaki YohSatoru Seo ASO Author Reflections 27 September 2018 Pages: 780 - 781
ASO Author Reflections: Hepatic Artery Infusion (HAI) Chemotherapy is Associated with Improved Survival Compared with Radioembolization (Y90) in Patients with Isolated Unresectable Colorectal Liver Metastases Mashaal DhirAmer H. Zureikat ASO Author Reflections 08 October 2018 Pages: 782 - 783
ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma Fabio BaganteTimothy M. Pawlik ASO Author Reflections 04 October 2018 Pages: 784 - 785
ASO Author Reflections: The Evolution of Minimally Invasive Liver Surgery and the Future with Robotics Sidrah KhanAllan Tsung ASO Author Reflections 08 October 2018 Pages: 786 - 787
ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited Byoung Hyuck KimEui Kyu ChieKyubo Kim ASO Author Reflections 15 October 2018 Pages: 788 - 789
ASO Author Reflections: Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis Tomoyuki Abe ASO Author Reflections 12 October 2018 Pages: 790 - 791
ASO Author Reflections: Role of Preoperative Chemotherapy in the Treatment of Pancreatic Neuroendocrine Liver Metastases Hop S. Tran CaoJean-Nicolas Vauthey ASO Author Reflections 17 October 2018 Pages: 792 - 793
ASO Author Reflections: Salvage Liver Transplant for Recurrent Hepatocellular Carcinoma After Treatments With Curative Intent Hala MuaddiGonzalo Sapisochin ASO Author Reflections 30 October 2018 Pages: 794 - 795
ASO Author Reflections: Evaluating the Impact of Wider Adoption of Minimally Invasive Liver Resection Patrick R. VarleyAllan Tsung ASO Author Reflections 01 November 2018 Pages: 796 - 797
ASO Author Reflections: Use of Retrospective Administrative Datasets in Rare Cancer Subtypes to Determine the Efficacy of Adjuvant Therapy Ibrahim NassourAdam C. Yopp ASO Author Reflections 12 November 2018 Pages: 798 - 799
ASO Author Reflections: Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms Yoshihide NannoHirochika Toyama ASO Author Reflections 22 August 2018 Pages: 800 - 801
The Prognostic Significance of Resection Margins After Pancreaticoduodenectomy Stijn van RoesselJennifer F. Tseng ASO Author Reflections 27 September 2018 Pages: 802 - 803
ASO Author Reflections: Even in Pancreatic Cancer, not all N Diseases are Created Equal Eran NizriGuy LahatJoseph Klausner ASO Author Reflections 03 October 2018 Pages: 804 - 805
ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma? Vincent P. GrootChristopher L. WolfgangJin He ASO Author Reflections 08 October 2018 Pages: 806 - 807
ASO Author Reflections: Neoadjuvant Treatment of Resectable and Borderline-Resectable Pancreatic Head Adenocarcinoma: Is FOLFIRINOX Better than Gem/Nab-Paclitaxel? Mashaal DhirAmer H. Zureikat ASO Author Reflections 08 October 2018 Pages: 808 - 809